Canadian Sec - Delayed Quote CAD

Nuran Wireless Inc. (NUR.CN)

0.1200 +0.0050 (+4.35%)
At close: April 24 at 3:50 PM EDT
Loading Chart for NUR.CN
DELL
  • Previous Close 0.1150
  • Open 0.0000
  • Bid 0.1200 x --
  • Ask 0.1400 x --
  • Day's Range 0.0000 - 0.0000
  • 52 Week Range 0.0000 - 0.3350
  • Volume 0
  • Avg. Volume 192,903
  • Market Cap (intraday) 4.86M
  • Beta (5Y Monthly) 3.25
  • PE Ratio (TTM) --
  • EPS (TTM) -0.3000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Nuran Wireless Inc., together with its subsidiaries, engages in the research, development, manufacture, marketing, and operation of digital electronic circuits and wireless telecommunication products in Canada, the United States, Europe, Africa, and internationally. The company's products include GSM LiteCell, a GSM base station for rural and roadside coverages, low density villages, remote sites, developing countries/emerging markets, and private networks; OC-2G, a carrier-grade GSM base station; Litecell-xG, a 2G, 3G, and 4G multi-standard base station; Nexus Core Network, a 2G, 3G, and 4G soft core network for small to medium-sized operations, including regional and rural mobile, as well as enterprise private networks; and network as a service. Nuran Wireless Inc. is based in Vancouver, Canada.

nuranwireless.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: NUR.CN

Performance Overview: NUR.CN

Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

NUR.CN
9.09%
S&P/TSX Composite index
4.37%

1-Year Return

NUR.CN
58.62%
S&P/TSX Composite index
5.70%

3-Year Return

NUR.CN
94.26%
S&P/TSX Composite index
14.51%

5-Year Return

NUR.CN
93.14%
S&P/TSX Composite index
31.22%

Compare To: NUR.CN

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NUR.CN

Valuation Measures

Annual
As of 4/24/2024
  • Market Cap

    4.86M

  • Enterprise Value

    17.42M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.38

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    5.43

  • Enterprise Value/EBITDA

    -2.09

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    3.21M

  • Net Income Avi to Common (ttm)

    -11M

  • Diluted EPS (ttm)

    -0.3000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    159.25k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Company Insights: NUR.CN

People Also Watch